First sublingual immunotherapy tablet for house dust mite allergic rhinitis may be U.S.-bound

LOS ANGELES – A sublingual immunotherapy tablet for house dust mite–induced allergic rhinitis achieved clinically meaningful improvement in symptoms along with less use of rescue medications and a favorable safety profile in a pivotal phase III trial, Dr. Hendrik Nolte reported at the annual...
Source: Skin and Allergy News - Category: Dermatology Source Type: news